NorthRock Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,185
| Closed | -$251K | – | 830 |
|
|
2024
Q3 | $251K | Buy |
2,185
+22
| +1% | +$2.53K | 0.01% | 550 |
|
|
2024
Q2 | $230K | Buy |
2,163
+13
| +0.6% | +$1.38K | 0.01% | 536 |
|
|
2024
Q1 | $208K | Buy |
2,150
+66
| +3% | +$6.38K | 0.01% | 572 |
|
|
2023
Q4 | $210K | Buy |
+2,084
| New | +$210K | 0.01% | 535 |
|
|
2023
Q1 | – | Sell |
-2,230
| Closed | -$202K | – | 349 |
|
|
2022
Q4 | $202K | Buy |
+2,230
| New | +$202K | 0.02% | 328 |
|
|
2022
Q3 | – | Sell |
-4,904
| Closed | -$415K | – | 323 |
|
|
2022
Q2 | $415K | Buy |
4,904
+6
| +0.1% | +$508 | 0.04% | 178 |
|
|
2022
Q1 | $430K | Sell |
4,898
-183
| -4% | -$16.1K | 0.04% | 194 |
|
|
2021
Q4 | $444K | Sell |
5,081
-5
| -0.1% | -$437 | 0.03% | 191 |
|
|
2021
Q3 | $416K | Sell |
5,086
-25
| -0.5% | -$2.05K | 0.03% | 176 |
|
|
2021
Q2 | $466K | Buy |
5,111
+222
| +5% | +$20.2K | 0.04% | 148 |
|
|
2021
Q1 | $418K | Sell |
4,889
-162
| -3% | -$13.9K | 0.04% | 135 |
|
|
2020
Q4 | $477K | Sell |
5,051
-503
| -9% | -$47.5K | 0.05% | 132 |
|
|
2020
Q3 | $483K | Buy |
5,554
+81
| +1% | +$7.04K | 0.05% | 121 |
|
|
2020
Q2 | $478K | Sell |
5,473
-83
| -1% | -$7.25K | 0.06% | 121 |
|
|
2020
Q1 | $458K | Buy |
5,556
+223
| +4% | +$18.4K | 0.06% | 112 |
|
|
2019
Q4 | $505K | Buy |
5,333
+1,919
| +56% | +$182K | 0.05% | 153 |
|
|
2019
Q3 | $297K | Buy |
+3,414
| New | +$297K | 0.04% | 169 |
|